Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Ngang Carol | Photo Stephen Collett
International conference delegates
International delegates attending the International Conference on the Right to Development hosted on the Bloemfontein Campus.

The International Conference on the Right to Development was held in Bloemfontein for the first time from 25 to 27 September 2019, hosted by the Free State Centre for Human Rights at the University of the Free State. This is the third in the international conference series launched in 2017 with the aim of advancing the right to development both in Africa and internationally. This year’s conference follows the previous two that were held at the Centre for Human Rights, University of Pretoria, in September 2017 and August 2018.  

Based on the theme, ‘The right to development and natural resource ownership’, the 3rd International Conference on the Right to Development offered the forum and opportunity to participants from a diversity of backgrounds and disciplines to interact and share knowledge on their research outputs, which extensively explored questions on how natural resource ownership could contribute to the realisation of the right to development. The keynote address was delivered by Prof John C Mubangizi, Dean of the Faculty of Law at the University of the Free State. 

The three-day conference registered a total of 35 participants and 27 presentations out of the 33 that were scheduled. Participants came from different countries, including South Africa, Botswana, Zimbabwe, the Democratic Republic of the Congo, Cameroon, Nigeria, Ghana, Kenya, Uganda, Ethiopia, and the United Kingdom. Some of those who were unable to attend had the opportunity to present their papers through Skype. The presentations stimulated exciting and robust debates. 

The International Conference Series on the Right to Development is jointly organised and co-sponsored by the Centre for Human Rights, University of Pretoria; the Thabo Mbeki African Leadership Institute, University of South Africa; and the Free State Centre for Human Rights, University of the Free Sate. In its three years of existence, it has progressively established a steady track record of publications, including journal articles in special editions of selected journals and collections of chapters in edited volumes. 

The next (fourth) conference is intended to be much bigger and is scheduled to take place in Kigali, Rwanda, in 2021. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept